logo
logo
  • Home
    • Home 1
    • Home 2
    • Home 3
    • Home 4
  • Pages
    • About us
    • Partner
    • Our Team
    • Faq
    • Error
  • Career
    • Career
    • Job Description
  • Research
    • Research & Development
    • Research Details
    • Product Pipeline
    • Invester
    • Scientific Platform
  • Shop
    • Shop
    • Product Details
    • Cart Page
    • Checkout Page
  • News
    • Masonry
      • Style one
      • Style two
    • Without Grid
      • Style one
      • Style two
    • Default Layout
      • Style one
      • Style two
    • News Details
  • Contact
  • Log In /
  • Sing Up

Welcome back

To keep connected with us please login with your personal info

Create account


Or

  • Sign in with facebook
  • Sign in with google

Log In

Forget password ?
  • Sign in with facebook
  • Sign in with google
New User ?
Create a new account

Hi Dear ? Sign up to join us

News & Media

  • Home
  • News & Media

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat

Catagories
  • Media
  • Events
  • Publication
  • News
Upcoming Event
  • recent post
    Pharmaceutical at 2019 cantor Healthcare conference

    September 5, 2019

    3.00pm

  • recent post
    Pharmaceutical at 2019 cantor Healthcare conference

    September 5, 2019

    3.00pm

Recent Posts
  • recent post
    Pharmaceutical at 2019 cantor Global Healthcare conference

    September 5, 2019

  • recent post
    Jozicular is flipping the pyramid, explains Steven Baert

    September 5, 2019

  • recent post
    Jozicular is flipping the pyramid, explains Steven Baert

    September 5, 2019

Follow Us
Tags
  • Care
  • Health
  • Innovation
  • Medicine
  • Technology
  • R & D
  • Pipeline
  • Cancer
Instagram

Bluebird bio and Jozicular Oncology Announce Strategic .

By Richard

Published :20 September 2019

  • White Palace, Brookyn, NYC
  • 3.00pm

Jozicular Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its products by leveraging two key pillars—first, a proprietary machine learning-based platform,A a at habitasse inceptos a quisque nibh ut arcu et dictum laoreet elit ante scelerisque libero consectetur erat non a suspendisse ad phasellus phasellus suspendisse gravida eu. Dapibus congue libero sem at dis a a adipiscing parturient eros diam parturient sodales consectetur quis.

Read More

Bluebird bio and Jozicular Oncology Announce Strategic .

By Ruhit

Published :20 September 2019

  • White Palace, Brookyn, NYC
  • 3.00pm

Jozicular Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its products by leveraging two key pillars—first, a proprietary machine learning-based platform,A a at habitasse inceptos a quisque nibh ut arcu et dictum laoreet elit ante scelerisque libero consectetur erat non a suspendisse ad phasellus phasellus suspendisse gravida eu. Dapibus congue libero sem at dis a a adipiscing parturient eros diam parturient sodales consectetur quis.

Read More

Bluebird bio and Jozicular Oncology Announce Strategic .

By jack

Published :20 September 2019

  • White Palace, Brookyn, NYC
  • 3.00pm

Jozicular Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its products by leveraging two key pillars—first, a proprietary machine learning-based platform,A a at habitasse inceptos a quisque nibh ut arcu et dictum laoreet elit ante scelerisque libero consectetur erat non a suspendisse ad phasellus phasellus suspendisse gravida eu. Dapibus congue libero sem at dis a a adipiscing parturient eros diam parturient sodales consectetur quis.

Read More
  • 1
  • 2
  • Next
footer logo
  • About
  • Research
  • Contact
© Jozicular All right reserved. Powered with by Zwin